Free Trial
NASDAQ:CMND

Clearmind Medicine (CMND) Stock Price, News & Analysis

Clearmind Medicine logo
$1.03 +0.03 (+3.00%)
Closing price 03:58 PM Eastern
Extended Trading
$1.00 -0.03 (-2.43%)
As of 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Clearmind Medicine Stock (NASDAQ:CMND)

Key Stats

Today's Range
$0.97
$1.03
50-Day Range
$0.84
$1.16
52-Week Range
$0.80
$2.18
Volume
55,141 shs
Average Volume
69,827 shs
Market Capitalization
$4.40 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CMND Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Clearmind Medicine and its competitors with MarketBeat's FREE daily newsletter.

CMND Stock News Headlines

BREAKING: The House just passed 3 pro-crypto bills!
THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. tc pixel
See More Headlines

CMND Stock Analysis - Frequently Asked Questions

Clearmind Medicine's stock was trading at $1.38 on January 1st, 2025. Since then, CMND shares have decreased by 25.4% and is now trading at $1.03.

Clearmind Medicine Inc. (NASDAQ:CMND) posted its quarterly earnings data on Thursday, June, 12th. The company reported ($0.16) earnings per share (EPS) for the quarter.

Shares of Clearmind Medicine reverse split on the morning of Tuesday, November 28th 2023.The 1-30 reverse split was announced on Tuesday, November 28th 2023. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, November 28th 2023. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

Clearmind Medicine (CMND) raised $9 million in an initial public offering on Tuesday, November 15th 2022. The company issued 1,300,000 shares at a price of $6.00-$8.00 per share. Aegis Capital Corp. acted as the underwriter for the IPO.

Clearmind Medicine's top institutional shareholders include AdvisorShares Investments LLC (4.82%).

Shares of CMND stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Clearmind Medicine investors own include NVIDIA (NVDA), Broadcom (AVGO), Adobe (ADBE), Arista Networks (ANET), Meta Platforms (META), AppLovin (APP) and e.l.f. Beauty (ELF).

Company Calendar

Last Earnings
6/12/2025
Today
8/22/2025
Next Earnings (Estimated)
9/15/2025
Fiscal Year End
10/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:CMND
CIK
1892500
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($1.10)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$5.26 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-164.79%
Return on Assets
-71.12%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.74
Quick Ratio
1.74

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.73 per share
Price / Book
1.41

Miscellaneous

Outstanding Shares
4,270,000
Free Float
N/A
Market Cap
$4.40 million
Optionable
Not Optionable
Beta
0.96
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

This page (NASDAQ:CMND) was last updated on 8/22/2025 by MarketBeat.com Staff
From Our Partners